pantoprazole has been researched along with Cerebellar Diseases in 2 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Cerebellar Diseases: Diseases that affect the structure or function of the cerebellum. Cardinal manifestations of cerebellar dysfunction include dysmetria, GAIT ATAXIA, and MUSCLE HYPOTONIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhana, A | 1 |
| Waters, MJ | 1 |
| Fazal, MW | 1 |
| Kimber, T | 1 |
| Fatuzzo, P | 1 |
| Portale, G | 1 |
| Scollo, V | 1 |
| Zanoli, L | 1 |
| Granata, A | 1 |
2 other studies available for pantoprazole and Cerebellar Diseases
| Article | Year |
|---|---|
Pantoprazole-induced hypomagnesaemia causing cerebellar syndrome and seizures.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Cerebellar Diseases; Female; Humans; Magnesium Defici | 2017 |
Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Biomarkers; Cerebellar Diseases; Dietary Supplements; | 2017 |